Clinical Research

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Address
Passeig De La Vall D'Hebron 119-129

Sponsor Overview

assignment
22
sponsored trials
science
48
molecules
location_city
48
research centres
public
2
countries
person_search
96
investigators

Specializations

Transplantation and Immunology

Kidney transplantation, renal graft failure, and solid organ transplantation are central areas of interest, with studies addressing HLA sensitization, immunosuppressive therapy, and Epstein-Barr virus replication in transplant recipients. The sponsor also funds work in hyperimmunized patients and transplant-associated viral control.

  • Kidney transplantation
  • HLA sensitization
  • Epstein-Barr virus
  • Solid organ transplantation
  • Immunosuppressive therapy

These activities reflect a strong focus on post-transplant immune management and infection-related complications in transplant medicine.

Infectious Diseases and Antimicrobial Treatment

The portfolio includes tuberculosis, strongyloidiasis, acute bacterial prostatitis, and febrile neutropenia, with additional interest in infectious disease control in vulnerable populations. Research also covers antibiotic discontinuation strategies and treatment approaches for difficult-to-manage infections.

  • Tuberculosis
  • Strongyloidiasis
  • Acute bacterial prostatitis
  • Febrile neutropenia
  • Infectious diseases

The sponsor is also involved in infection-focused studies in immunocompromised and paediatric settings.

Neurology, Stroke, and Migraine

Clinical research extends to acute ischemic stroke due to large vessel occlusion and migraine, including biomarker-oriented work in headache disorders. These studies connect neurovascular care with symptom control and treatment response assessment.

  • Acute ischemic stroke
  • Large vessel occlusion
  • Migraine
  • Neurovascular intervention
  • Biomarkers

There is also interest in linking clinical outcomes with measurable biological changes in neurological disease.

Oncology and Hepatobiliary Surgery

The sponsor funds studies in relapsed/refractory neuroblastoma, solid tumours, and liver tumors, alongside research in minimally invasive liver surgery. Additional work addresses anal high-grade squamous intraepithelial lesions and cancer-related infectious risk in paediatric patients.

  • Neuroblastoma
  • Solid tumours
  • Liver tumors
  • Minimally invasive liver surgery
  • Anal high-grade squamous intraepithelial lesions

These topics show a broad engagement with oncologic disease management and procedure-guided tumour detection.

Metabolic, Renal, and Maternal Health

Research interests also include type 2 diabetes, chronic kidney disease, diabetic retinopathy, and advanced chronic liver disease. The sponsor is active in preeclampsia prevention and in conditions related to adrenal insufficiency and pediatric endocrine care.

  • Type 2 diabetes
  • Chronic kidney disease
  • Diabetic retinopathy
  • Preeclampsia
  • Adrenal insufficiency

These studies span metabolic disease, renal complications, and pregnancy-related risk management.

Sponsored Trials

Trial Name Country Status
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Topical Ocular DS101 in Healthy SubjectsSpain SpainRecruiting
Acetylsalicylic Acid Discontinuation Between Weeks 24 and 26 for Prevention of Preterm Preeclampsia in Pregnant Women at High RiskSpain SpainNot Yet Recruiting
Early Discontinuation of Antibiotic Therapy in High-Risk Febrile Neutropenic Pediatric Oncology PatientsSpain SpainRecruiting
Efficacy and Safety of Fixed-Dose Ivermectin Versus Weight-Adjusted Ivermectin in Treating Uncomplicated Strongyloidiasis in Immunocompetent AdultsSpain SpainRecruiting
Efficacy of Topical Sinecatechins as Adjuvant to Trichloroacetic Acid in Treating Anal High-Grade Squamous Intraepithelial LesionsSpain SpainRecruiting
Evaluation of Fosfomycin Trometamol, Cefixime, and Ciprofloxacin Hydrochloride in Acute Bacterial Prostatitis: A Randomized, Open-Label, Multicenter TrialSpain SpainRecruiting
Evaluation of High-Dose Rifampicin Safety in Adult Patients with Complex Drug-Susceptible Pulmonary and Extrapulmonary Tuberculosis Using a Drug CombinationSpain SpainThe Netherlands The NetherlandsRecruiting
Evaluation of High-Dose Rifampicin, Moxifloxacin, and Linezolid Regimen in Bacilliferous Pulmonary Tuberculosis: A Randomized Controlled TrialSpain SpainNot Recruiting
Evaluation of Immunosuppressive Therapy Individualization Using Biomarkers in Living Donor Kidney Transplant Recipients: A Multicenter Randomized StudySpain SpainNot Yet Recruiting
Evaluation of Safety, Tolerability, and Pharmacokinetics of Topical Ocular DS101 in Diabetic Retinopathy: A Phase I Randomized, Double-Blind, Placebo-Controlled StudySpain SpainNot Yet Recruiting
1–10 of 22
1 / 3

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 48 total (4% not shared with other sponsors)

This sponsor works with 48 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
33%
Return partnership rate
16 of 48 sites collaborated multiple times

This sponsor has worked with 48 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Immune system processes3 trials
    65 other sponsors
  • 2.
    Bacterial Infections and Mycoses2 trials
    180 other sponsors
  • 3.
    Cardiovascular Diseases2 trials
    359 other sponsors
  • 4.
    Digestive System Diseases2 trials
    280 other sponsors
  • 5.
    Eye Diseases2 trials
    138 other sponsors
  • 6.
    Nervous System Diseases2 trials
    449 other sponsors
  • 7.
    Not possible to specify2 trials
    220 other sponsors
  • 8.
    Nutritional and Metabolic Diseases2 trials
    211 other sponsors
  • 9.
    Diagnosis1 trial
    83 other sponsors
  • 10.
    Hormonal diseases1 trial
    89 other sponsors
  • 11.
    Male Urogenital Diseases1 trial
    111 other sponsors
  • 12.
    Neoplasms1 trial
    853 other sponsors
  • 13.
    Parasitic Diseases1 trial
    9 other sponsors
  • 14.
    Pathological Conditions, Signs and Symptoms1 trial
    91 other sponsors
  • 15.
    Surgical Procedures, Operative1 trial
    58 other sponsors
  • 16.
    Virus Diseases1 trial
    182 other sponsors

Partnered Research Centres

48 centres
location_city
assignment63
Althaia Xarxa Assistencial Universitaria De Manresa Fundacio Privada
Address
Carrer Del Doctor Joan Soler 1-3, 08243 Manresa
Learn morearrow_forward
location_city
assignment86
Area De Salud De Burgos Y Soria
Address
Avenida De Las Islas Baleares 3, 09006 Burgos
Learn morearrow_forward
location_city
assignment364
Bellvitge University Hospital
Address
Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Learn morearrow_forward
location_city
assignment59
Complexo Hospitalario Universitario De Pontevedra
Address
Calle Mourente S/n, 36164 Pontevedra
Learn morearrow_forward
location_city
assignment27
Consorci Sanitari De Terrassa
Address
Carretera De Torrebonica S/N, 08227 Terrassa
Learn morearrow_forward
location_city
assignment23
Consorci Sanitari Del Maresme
Address
Carretera De Cirera 230, 08304 Mataró
Learn morearrow_forward
Page 1 of 8

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.